コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 hondrial function and longevity, by reducing protein kinase C-beta.
2 is increased after PMA-evoked activation of protein kinase C-beta.
3 ding those for annexin VI, interleukin-4 and protein kinase C-beta.
4 between PKCI-1 and the regulatory domain of protein kinase C-beta.
5 able transfection of expression plasmids for protein kinases C beta 1 (PKC beta 1) or PKC beta 2 into
6 lted in a preferential decrease in epidermal protein kinase C-beta 2 (PKC-beta 2) compared with PKC-a
9 x, including synaptotagmin I, cAMP-dependent protein kinase C beta, apolipoprotein E, protein phospha
11 a mechanism dependent on SNARE proteins and protein kinase C-beta but independent of dopamine D(2) r
12 binding to C2 domains of synaptotagmin I and protein kinase C-beta by nuclear magnetic resonance spec
13 Among the protein knase C isoforms tested, protein kinase C beta, delta, and epsilon were most effe
14 Haploinsufficiency or complete deficiency of protein kinase C beta, Fyn, CD22, Galphaq, or Galpha11 h
15 the Src-family protein tyrosine kinase Lyn, protein kinase C beta I/II (PKCbetaI/II), and Erk2-speci
17 the unphosphorylated turn motif (Thr(641) in protein kinase C beta II), one of three priming sites ph
18 tion of the interaction with Hsp70 slows the protein kinase C beta II-mediated recovery of cells from
21 trast, treatment with D-alpha-tocopherol and protein kinase-C beta-isoform inhibition (LY333531) prev
22 ds induced by diabetes mellitus can activate protein kinase C-beta isoforms and selectively inhibit i
24 ling, but GC cells signaled less through the protein kinase C-beta-NF-kappaB pathway and produced str
25 Using the HL-60 cell variant deficient in protein kinase C-beta (PKC-beta) and several stable PKC-
30 osolic phospholipase A2-alpha (cPLA2-alpha), protein kinase C-beta (PKC-beta), and synaptotagmin-IA (
33 we identify the calcium-regulated classical protein kinase C beta (PKCbeta) as a repressor of myogen
34 the recommended dose of enzastaurin, an oral protein kinase C beta (PKCbeta) inhibitor, for phase II
40 d that combined small-molecule inhibition of protein kinase C-beta (PKCbeta) and glycogen synthase ki
41 l insulin signaling, through the activity of protein kinase C-beta (PKCbeta) and nuclear factor kappa
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。